LeMaitre Vascular Inc.
Find Ratings ReportsLEMAITRE VASCULAR INC's gross profit margin for the fourth quarter of its fiscal year 2023 has increased when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the subsector, the net income growth has not. LEMAITRE VASCULAR INC is extremely liquid. Currently, the Quick Ratio is 4.36 which clearly shows the ability to cover any short-term cash needs. LMAT managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.
During the same period, stockholders' equity ("net worth") has increased by 11.07% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q4 FY23 | Q4 FY22 |
---|---|---|
Net Sales ($mil) | 48.88 | 40.95 |
EBITDA ($mil) | 12.6 | 9.06 |
EBIT ($mil) | 10.15 | 6.77 |
Net Income ($mil) | 8.47 | 5.63 |
Balance Sheet | Q4 FY23 | Q4 FY22 |
---|---|---|
Cash & Equiv. ($mil) | 105.07 | 82.69 |
Total Assets ($mil) | 346.78 | 310.48 |
Total Debt ($mil) | 19.1 | 16.6 |
Equity ($mil) | 297.9 | 268.2 |
Profitability | Q4 FY23 | Q4 FY22 |
---|---|---|
Gross Profit Margin | 70.0 | 65.45 |
EBITDA Margin | 25.76 | 22.12 |
Operating Margin | 20.77 | 16.54 |
Sales Turnover | 0.56 | 0.52 |
Return on Assets | 8.68 | 6.64 |
Return on Equity | 10.11 | 7.69 |
Debt | Q4 FY23 | Q4 FY22 |
---|---|---|
Current Ratio | 6.51 | 6.39 |
Debt/Capital | 0.06 | 0.06 |
Interest Expense | 0.0 | 0.0 |
Interest Coverage | 0.0 | 0.0 |
Share Data | Q4 FY23 | Q4 FY22 |
---|---|---|
Shares outstanding (mil) | 22.33 | 22.09 |
Div / share | 0.14 | 0.13 |
EPS | 0.38 | 0.25 |
Book value / share | 13.34 | 12.14 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 116907.0 | 145440.0 |
BUY. This stock's P/E ratio indicates a premium compared to an average of 49.88 for the Miscellaneous Manufacturing subsector and a significant premium compared to the S&P 500 average of 27.95. For additional comparison, its price-to-book ratio of 5.06 indicates a premium versus the S&P 500 average of 4.68 and a premium versus the subsector average of 4.96. The price-to-sales ratio is well above both the S&P 500 average and the subsector average, indicating a premium. Upon assessment of these and other key valuation criteria, LEMAITRE VASCULAR INC proves to trade at a premium to investment alternatives.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LMAT 50.37 | Peers 49.88 | LMAT 41.01 | Peers 33.16 | |||||||||||||||||||||
Average. An average P/E ratio can signify an subsector neutral price for a stock and an average growth expectation. LMAT is trading at a valuation on par with its peers. |
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. LMAT is trading at a premium to its peers. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
LMAT 36.49 | Peers 24.07 | LMAT 2.18 | Peers 0.91 | |||||||||||||||||||||
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations. LMAT is trading at a significant premium to its peers. |
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. LMAT trades at a significant premium to its peers. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
LMAT 5.06 | Peers 4.96 | LMAT 44.08 | Peers 126.83 | |||||||||||||||||||||
Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. LMAT is trading at a valuation on par with its peers. |
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, LMAT is expected to significantly trail its peers on the basis of its earnings growth rate. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
LMAT 7.79 | Peers 6.41 | LMAT 19.69 | Peers 8.91 | |||||||||||||||||||||
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. LMAT is trading at a premium to its subsector on this measurement. |
Higher. A sales growth rate that exceeds the subsector implies that a company is gaining market share. LMAT has a sales growth rate that significantly exceeds its peers. |
|||||||||||||||||||||||